Insulin- Fasting (FI) is a type of blood test in which a patient fasts for 12 hours to check how much insulin is in the bloodstream. Insulin is a type of hormone that the pancreas makes to regulate the level of glucose. This test assesses metabolic syndrome, polycystic ovary syndrome (PCOS), and hypoglycemia.

Molecular Diagnostics and Therapy is an NABL & NABH Accredited Diagnostic Centre and Pathology Lab that uses cutting-edge immunoassay technology to provide accurate fasting insulin testing. We have well-trained lab staff and guarantee results that will be available in a timely fashion to enable early diagnosis and treatment planning.

About Insulin – Fasting (FI)

Insulin is a hormone produced by the pancreas to regulate the blood glucose level. Insulin levels are measured after an 8-12 hour fast, which gives the physician a snapshot of insulin levels before any breakfast, lunch, or snacks have been consumed.

Fasting Insulin is sometimes ordered in combination with Fasting Blood Sugar (FBS) to assess insulin sensitivity and to calculate the insulin sensitivity indices like HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), if clinically appropriate.

What is an Insulin – Fasting (FI) Test?

The Insulin – Fasting (FI) Test shows the level of blood insulin at the end of the night-time fast. The results give clues to health professionals if the pancreas is producing enough insulin and whether the body cells are effectively utilizing insulin. High (above normal) insulin and low glucose levels can be considered insulin resistance, poor glucose utilization, a disorder of the pancreas, or overproduction of insulin.

Common Reasons for an Insulin – Fasting (FI) Test

Your doctor should recommend this test to:

• Evaluate insulin resistance
• Diagnose prediabetes or Type 2 diabetes
• Investigate unexplained low blood sugar (hypoglycemia)
• Assess pancreatic insulin production
• Evaluate metabolic syndrome
• Investigate obesity-related metabolic disorders
• Assess polycystic ovary syndrome (PCOS)
• Diagnose insulinoma (insulin-producing tumor)
• Monitor response to lifestyle or diabetes treatment
• Calculate insulin resistance indices such as HOMA-IR

Conditions Evaluated

The Insulin – Fasting (FI) Test helps evaluate:

• Insulin resistance
• Prediabetes
• Type 2 diabetes mellitus
• Metabolic syndrome
• Hyperinsulinemia
• Hypoglycemia
• Polycystic ovary syndrome (PCOS)
• Insulinoma
• Pancreatic endocrine disorders
• Disorders of glucose metabolism

Benefits of Insulin – Fasting (FI) Test

• Measures baseline insulin production
• Helps detect insulin resistance at an early stage
• Supports diagnosis of diabetes and metabolic disorders
• Assists in evaluating pancreatic function
• Useful for calculating insulin resistance (HOMA-IR)
• Simple and minimally invasive blood test
• Supports monitoring of treatment and lifestyle interventions

Risks and Limitations

Safety

• Safe and routine blood test with minimal risk.
• Mild pain, bruising, or slight bleeding at the blood collection site should occur temporarily.

Limitations

• Proper fasting is essential for accurate results.
• Stress, illness, medications, and hormonal conditions should influence insulin levels.
• Results should be interpreted together with Fasting Blood Sugar (FBS), HbA1c, Post Prandial Blood Sugar (PPBS), and other clinical findings.
• Additional investigations should be recommended depending on the patient's symptoms and medical history.

Conclusion

Insulin – Fasting (FI) test is an important lab test, a measure of insulin production, insulin resistance, and glucose metabolism. It is important for the prompt diagnosis and treatment of prediabetes, diabetes, metabolic syndrome, PCOS, pancreatic disease, and hypoglycemia. At Molecular Diagnostics and Therapy, testing is the foundation for a strong laboratory system and represents a valuable tool for ensuring your long-term metabolic health, with an accurate report and explanation of fasting insulin results.